Table 1.
Randomized controlled trails of self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes not using insulin: patient characteristics
| Reference; country | Schwedes 2002; Germany and Austria9,10 | Farmer 2007; UK11–13 | Allen 1990; USA16 | Davidson 2005; USA17 | Fontbonne 1989; France18 | Guerci 2003; France19 | Muchmore 1994; USA20 | O’Kane 2008; UK21 | Barnett 2008; Seven countries14 |
|---|---|---|---|---|---|---|---|---|---|
| Previous use of SMBG | No use of SMBG in the last 6 months | No use of SMBG twice a week or more over the previous 3 months | No | ? | ? | No | No use of SMBG in the last 3 months | No | No current management with SMBG |
| Male (%) | 52 | 57 | 100 | 26 | 62 | 55 | 39 | 60 | 52 |
| Age (years)a | ~60 (45–70) | 65.7 (≥25) | 58 | ~50 | ~55 | ~62 (40–75) | ~59 (40–75) | ~59 (<70) | ~56 (40–80) |
| HbA1c(%)a | ~8.4 (7.5–10) | 7.5 (≥6.2) | ~12.0 | ~8.5 | ~8.3 | 9.0 (7.5–11) | ~10.4 (9.5–13.5) | 8.7 | 8.1 (7–10) |
| Diabetes duration (years)a | ~5.3 (≥0.25) | 3 | ~7.9 | ~5.6 | ~12.7 (≥3) | ~8.0 (≥1) | ~5.5 (≥1) | 0b | 2.8 |
| Body mass index (kg/m2)a | ~31.5 (>25) | ~31.3 | ? (weight: ~93 kg) | 32.5 | ~26.7 | ~30.1 | ~34.2 (27.5–44) | ~33 | ~30.4 |
| Treatment | Diet (?%) or diet and oral blood glucose-lowering treatment (?%) | Diet (27%) or diet and oral blood glucose-lowering treatment (73%) | Diet (15%) or diet and oral blood glucose-lowering treatment (85%) | Diet (2%) or diet and oral blood glucose-lowering treatment (98%; 14% triple therapy) | Diet (?%) or diet and oral blood glucose-lowering treatment (?%) | Oral blood glucose-lowering treatment | Diet (26%) or diet and oral blood glucose-lowering treatment (74%) | Newly diagnosed patients | Diet (29%) for ≥3 months or diet and oral blood glucose-lowering treatment (71%) |
a
Presented data are means or median with between brackets the inclusion range.
b
Newly diagnosed patients with type 2 diabetes were included.